跳至主要内容
临床试验/jRCT1070240032
jRCT1070240032尚未招募不适用

Study of selective neck dissection navigated by sentinel node biopsy for T3-4aN0 advanced oral cancers (multiinstitutional randomized control study)

PDR PHARMA0 个研究点目标入组 187 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
187
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Patients with T3-4 oral squamous cell carcinoma without lymph node metastasis 2) Patients with no previous treatment for head and neck cancer 3) Patients who are at least 18 years old at the time of consent 4) Patients with written consent from the patient.

排除标准

  • Cases with PORT indication (extracapsular invasion, multiple cervical metastases) 2) Cases previously treated with cervical radiation 3) Pregnant or suspected pregnant 4) Cases with serious complications that do not tolerate radical surgery in the judgment of the attending physician 5) Cases deemed inappropriate for this study by the treating physician for other reasons

结局指标

主要结局

-

3-year neck recurrence-free survival rate

次要结局

未报告次要终点

研究者

发起方
PDR PHARMA

相似试验